CSIMarket
 


Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's Net Income Growth by Quarter and Year

Merck And Co Inc 's Net Income results by quarter and year




MRK Net Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -2,092.00 2,364.00 1,778.00
III Quarter September - 2,945.00 1,907.00 1,958.00
II Quarter June - 3,010.00 2,644.00 1,716.00
I Quarter March 3,186.00 3,219.00 2,862.00 741.00
FY   3,186.00 7,082.00 9,777.00 6,193.00



MRK Net Income first quarter 2021 Y/Y Growth Comment
Merck And Co Inc reported decrease in Net Income in the first quarter by -1.03% to $ 3,186.00 millions, from the same quarter in 2020.
The decrease in the first quarter Merck And Co Inc 's Net Income compares unfavorably to the Company's average Net Income growth of 6.95%.

Looking into first quarter results within Major Pharmaceutical Preparations industry 21 other companies have achieved higher Net Income growth. While Merck And Co Inc ' s Net Income decline of -1.03% ranks overall at the positon no. 1118 in the first quarter.




MRK Net Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - 32.96 % -
III Quarter September - 54.43 % -2.6 % -
II Quarter June - 13.84 % 54.08 % -12.05 %
I Quarter March -1.03 % 12.47 % 286.23 % -52.38 %
FY   - -27.56 % 57.87 % 156.12 %

Financial Statements
Merck And Co Inc 's first quarter 2021 Net Income $ 3,186.00 millions MRK's Income Statement
Merck And Co Inc 's first quarter 2020 Net Income $ 3,219.00 millions Quarterly MRK's Income Statement
New: More MRK's historic Net Income Growth >>


MRK Net Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - 23.96 % -9.19 %
III Quarter September - -2.16 % -27.87 % 14.1 %
II Quarter June - -6.49 % -7.62 % 131.58 %
I Quarter March - 36.17 % 60.97 % -
FY (Year on Year)   - -27.56 % 57.87 % 156.12 %




Net Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #22
Healthcare Sector #76
Overall #1118

Net Income Y/Y Growth Statistics
High Average Low
146.86 % 6.95 % -87.73 %
(Sep 30 2018)   (Dec. 30, 2010)
Net Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #22
Healthcare Sector #76
Overall #1118
Net Income Y/Y Growth Statistics
High Average Low
146.86 % 6.95 % -87.73 %
(Sep 30 2018)   (Dec. 30, 2010)

Net Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Merck And Co Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
770.19 % 27.67 % -94.94 %
IV. Quarter  


MRK's I. Quarter Q/Q Net Income Comment
I. Quarter 2021Cyclical Merck and Co Inc in the circumstances net loss of $ 3,186.00 millionsCyclical circumstances have added to Merck and Co Inc 's restoration of profitability, as MRK postNet Income of $ 3,186.00 millions in the I. Quarter 2021 emerging from net loss-2,092.00 millions in the forth quarter. Merck and Co Inc announced in the I. Quarter 2021 Net Income of $ 3,186.00 millions compare to net loss recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Net Income growth. While Merck And Co Inc 's Net Income growth quarter on quarter, overall rank is 0.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Income Q/Q Growth Statistics
High Average Low
770.19 % 27.67 % -94.94 %
IV. Quarter  


MRK's I. Quarter Q/Q Net Income Comment
I. Quarter 2021Periodic Merck and Co Inc in the factors net loss of $ 3,186.00 millionsPeriodic factors have led to Merck and Co Inc 's rebound to profitability, as MRK deliverNet Income of $ 3,186.00 millions in the I. Quarter 2021 coming of net loss-2,092.00 millions in the forth quarter. Merck and Co Inc announced in the I. Quarter 2021 Net Income of $ 3,186.00 millions compare to net loss recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Net Income growth. While Merck And Co Inc 's Net Income growth quarter on quarter, overall rank is 0.


Merck And Co Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Net Income 12 Months Ending $ 7,049.00 $ 7,082.00 $ 11,538.00 $ 10,500.00 $ 10,134.00
Y / Y Net Income Growth (TTM) -30.44 % -27.56 % 25.54 % 13.61 % 21.89 %
Year on Year Net Income Growth Overall Ranking # 1064 # 1266 # 530 # 313 # 468
Seqeuential Net Income Change (TTM) -0.47 % -38.62 % 9.89 % 3.61 % 3.65 %
Seq. Net Income Growth (TTM) Overall Ranking # 1118 # 1802 # 694 # 337 # 556




Cumulative Net Income growth Comment
Merck And Co Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -30.44% year on year, at Mar 31 2021 compare to the -27.56% decrease at Dec 31 2020. If the Merck And Co Inc 's fiscal year would end at Mar 31 2021, annual Net Income would be $7,049 millions.

In the Healthcare sector 71 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 1064, from total ranking in previous quarter at 1266.

Net Income TTM Q/Q Growth Statistics
High Average Low
146.86 %
6.95 %
-87.73 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 22
Healthcare Sector # 72
Overall # 1064

Net Income TTM Y/Y Growth Statistics
High Average Low
575.58 %
38.15 %
-92.46 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 76
S&P 500 # 1118
Cumulative Net Income growth Comment
Merck And Co Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -30.44% year on year, at Mar 31 2021 compare to the -27.56% decrease at Dec 31 2020. If the Merck And Co Inc 's fiscal year would end at Mar 31 2021, annual Net Income would be $7,049 millions.

In the Healthcare sector 71 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 1064, from total ranking in previous quarter at 1266.

Net Income TTM Q/Q Growth Statistics
High Average Low
146.86 %
6.95 %
-87.73 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 22
Healthcare Sector # 72
Overall # 1064

Net Income TTM Y/Y Growth Statistics
High Average Low
575.58 %
38.15 %
-92.46 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 76
S&P 500 # 1118




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
MRK's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for MRK's Competitors
Net Income Growth for Merck And Co Inc 's Suppliers
Net Income Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar Net Income drop for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2021
Merck and Co Inc -1.03%$ -1.025 millions
Utah Medical Products Inc-3.69%$ -3.694 millions
Eli Lilly And Company-6.95%$ -6.948 millions
Amgen Inc -9.81%$ -9.808 millions
Baxter International Inc -9.91%$ -9.910 millions
Phibro Animal Health Corp-9.93%$ -9.925 millions
Alexion Pharmaceuticals Inc -12.27%$ -12.267 millions
Alpha Pro Tech Ltd-12.54%$ -12.541 millions
Atrion Corporation-13.17%$ -13.171 millions
Neurocrine Biosciences Inc -14.17%$ -14.171 millions
Avanos Medical Inc -16.42%$ -16.418 millions
Msa Safety Inc-16.44%$ -16.442 millions
National Research Corporation-21.46%$ -21.463 millions
Iradimed Corp-21.61%$ -21.612 millions
Corcept Therapeutics Inc-21.95%$ -21.952 millions
Catalyst Pharmaceuticals Inc -26.50%$ -26.501 millions
Stryker Corp-38.74%$ -38.742 millions
Teleflex Incorporated-42.92%$ -42.916 millions
Vyne Therapeutics Inc -48.92%$ -48.923 millions
Anika Therapeutics Inc -51.01%$ -51.010 millions
Viemed Healthcare Inc -60.31%$ -60.311 millions
Electromed Inc -65.75%$ -65.746 millions
Endo International Plc-68.04%$ -68.041 millions
Acadia Healthcare Company Inc -69.24%$ -69.240 millions
The Pennant Group Inc -69.36%$ -69.362 millions
Biogen Inc -70.95%$ -70.946 millions
Supernus Pharmaceuticals inc -73.54%$ -73.538 millions
Biomarin Pharmaceutical Inc-78.65%$ -78.655 millions
United Therapeutics Corporation-79.45%$ -79.448 millions
Align Technology inc -86.80%$ -86.801 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MOS's Profile

Stock Price

MOS's Financials

Business Description

Fundamentals

Charts & Quotes

MOS's News

Suppliers

MOS's Competitors

Customers & Markets

Economic Indicators

MOS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071